GlassScriptPhysician profile
Michelle Horev
NPI 1831868421
$4,617.57
in general payments reported to CMS, 2019-2025
23 companies · $2,189 in 2025
The $2,189 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.98 · 2023: $801 · 2024: $1,535 · 2025: $2,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,316 · Education: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,316.39 |
| Education | $208.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $853.13 | 2022-2025 | Farxiga, Wainua, Lokelma |
| Actelion Pharmaceuticals US, INC. | $581.49 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Merck Sharp & Dohme LLC | $566.60 | 2023-2025 | Winrevair, Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $348.61 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $331.55 | 2023-2025 | Onpattro, Amvuttra |
| Impulse Dynamics (USA) INC. | $325.47 | 2023-2024 | Optimizer, Optimizer |
| Novo Nordisk INC | $304.07 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $292.35 | 2023-2025 | |
| Boston Scientific Corporation | $151.76 | 2024 | Watchman Access System |
| Bridgebio Pharma, INC. | $141.93 | 2025 | Attruby |
| Janssen Pharmaceuticals, INC | $136.93 | 2022-2024 | Xarelto |
| Medtronic, INC. | $136.45 | 2024 | Cobalt Dr Mri Surescan |
| United Therapeutics Corporation | $107.57 | 2024-2025 | Tyvaso, Remodulin |
| Novartis Pharmaceuticals Corporation | $73.95 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $69.08 | 2023-2024 | Inpefa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $51.37 | 2024-2025 | Camzyos |
| Biosense Webster, INC. | $26.73 | 2024 | Carto 3 |
| Cleerly, INC. | $25.00 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Kestra Medical Technology Services, INC. | $20.16 | 2024 | Assure Wcd |
| Endotronix, INC. | $20.00 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Daiichi Sankyo INC. | $19.78 | 2022 | |
| Amgen INC. | $18.53 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.06 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Horev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.